PHA
CN
Our Mission
Vision and Values
  • National in-construction production lines (tons)
    10000+
  • Founders' R&D Experience (years)
    37+
  • Founders' Mass Production Experience (years)
    10+

Your Current Location: Home · About Us · PhaBuilder '4P' Strategy ·
About Us
PhaBuilder: Focused on the Biomanufacturing of PHA.
Committed to bringing a better green life to people

PhaBuilder's technology is derived from Tsinghua University, initiated and founded by Professor George Guo-Qiang CHEN, a top global synthetic biology expert and the first Chinese recipient of the IMES Award (International Metabolic Engineering Award).

Relying on a self-developed halophilic bacterial chassis system for 30 consecutive years, PhaBuilder continuously develops its core product PHA (Polyhydroxyalkanoate) and promotes the realization of the PHA-based "4P" strategy for enterprise. This includes PHAmily (continuously exploring the PHA family with over 10 billion combinations), PHAbrary (a series of polymer material application solutions), PHAdustry (Industry 4.0 in the era of biomanufacturing, and global industrialization based on the NGIB(Next Generation Industrial Biotechnology) system commercialization of PHA).

PhaBuilder also possesses unique non-grain biomanufacturing technology and is currently constructing the world's largest "NGIB" production line with an annual capacity of 30,000 tons. In the future, PhaBuilder will provide sustainable solutions based on green bio-based materials to global customers by positioning itself as “a global leader in synthetic biology and bio-manufacturing”.

  • Industry
    Partners
PhaBuilder Strategy
PhaBuilder '4P' Strategy
PHAmily
PHAmily
Exploring PHAs
Over 10 billion Combinations
The Diverse Family of PHAs
PHAbrary
PHAbrary
Applications Development
Performance Meet Customer Requirements
Material Application Database
PHAdustry
PHAdustry
Industrialization
PHA Complete Solution
Entering into a Myriad of Industries
PHA Life
PHA Life
Commercialization
Reaching the End Customers
Reaching into Thousands of Households
Development History
PhaBuilder Development History
1994
The founder returned to China and joined Tsinghua University.
Commencing 30 years of research in synthetic biology.
2021
PhaBuilder Company Established
Takes the lead in completing 200-ton scale production
2022
Establishment of a Flexible Manufacturing Line (Beijing)
Create a Benchmark for Biomanufacturing + Industry 4.0
2023
Starting construction of the world's largest NGIB production line (Hubei)
Establishment of Weiqi Bio dedicated to industrial scale-up
Achieve tens of millions of yuan in PHA product orders
Bring breakthrough solutions for eco-friendly materials.
  • 1994
    The founder returned to China and joined Tsinghua University.
    Commencing 30 years of research in synthetic biology.
  • 2021
    PhaBuilder Company Established
    Takes the lead in completing 200-ton scale production
  • 2022
    Establishment of a Flexible Manufacturing Line (Beijing)
    Create a Benchmark for Biomanufacturing + Industry 4.0
  • 2023
    Starting construction of the world's largest NGIB production line (Hubei)
    Establishment of Weiqi Bio dedicated to industrial scale-up
    Achieve tens of millions of yuan in PHA product orders
    Bring breakthrough solutions for eco-friendly materials.
Management Team
Composed of individuals from academia, business, and industry.
Professor Guoqiang Chen
Director of the Center for Synthetic and Systems Biology at Tsinghua University
Professor Guoqiang Chen is a leading global expert in synthetic biology and a pioneering figure in the field of metabolic engineering. He serves as a professor at Tsinghua University and is the director of the Center for Synthetic and Systems Biology. He is the principal scientist for the National 973 "Synthetic Biology" project and a major national special project. He is also the first Chinese recipient of the "International Metabolic Engineering Award (IMES Award)."
Professor Chen is also the co-editor-in-chief of the world-renowned journal in synthetic biology, Synthetic and Systems Biotechnology (known as SSB). He has published over 400 papers on microbial technology and biomaterials in international academic journals such as Chemical Reviews and Chemical Society Reviews. His work has been cited over 25,000 times according to Web of Science, with an H-index of 78. He has been granted more than 50 patents and has 50 patents pending.
Xuanming Xu
Chairman of PhaBuilder
Ms. Xu Xuanming, as the Chairman of PhaBuilder, has always been committed to introducing innovative management mechanisms and accelerating the global business layout, aiming to make PhaBuilder a leading enterprise serving the world with synthetic biology.
Ms. Xu Xuanming has been dedicated to the cause of low-carbon sustainable development for a long time. With nearly 20 years of senior management experience in multinational companies, she has served in the Fortune Global 500 company Siemens, empowering the company's digital transformation with an international perspective, achieving ESG goals, and promoting the construction and implementation of standard systems and landmark projects in China's low-carbon related industries. She has led the exploration of innovative solution businesses from scratch and has profound accumulation in the strategic positioning, product development, marketing, industrial chain integration, and innovative models of multinational enterprises.
She firmly believes that PhaBuilder can benefit humanity with the concept of "using microbes to change the world, building a green future." With the "next-generation industrial biotechnology" as the engine, it will create high-performance materials for various industries, apply them to ever-changing scenarios, make PHA Life a new lifestyle concept that is deeply rooted in people's hearts, and continue to promote humanity towards a green future. Ms. Xu Xuanming graduated from the Department of Thermal Engineering at Tsinghua University with a bachelor's degree, and obtained a master's degree in International Business Administration from the School of Economics and Management of Tsinghua University and MIT Sloan School of Management. She later explored entrepreneurship and innovation at the Anderson School of Management at UCLA and Stanford Graduate School of Business in the United States.
  • Fuqing Wu
    Co-founder
    Mr. Wu Fuqing is an expert in synthetic biology and the transformation of scientific research achievements. He is a Ph.D., a member of the Beijing Municipal Committee, a member of the Bio-based Materials Committee of the Chinese Society of Biotechnology, and an associate researcher at the School of Life Sciences, Tsinghua University. Mr. Wu has extensive experience in the field of synthetic biology research and the transformation of industrial achievements. He has presided over three National Natural Science Foundation projects, published more than 40 papers, and applied for 15 patents.
  • Yuxuan Lan
    VP
    A globally renowned entrepreneur leader in the field of synthetic biology, he has a profound understanding of global synthetic biology market trends and industrial development.
    In 2021, as a founding team member, he co-founded the innovative synthetic biology company PhaBuilder, promoting the marketization of synthetic biology products including PHA and tetrahydropyridine using a new halophilic bacterial chassis.
  • Ouyang Pengfei
    VP
    He holds a Ph.D. in Biology from Tsinghua University and he is a postdoctor in Business Administration. With nearly 10 years of frontline research experience in the field of synthetic biology and bioengineering, he has published and applied for multiple SCI papers and invention patents. During his academic years, he served as the chairman of the Graduate Student Union of the School of Life Sciences at Tsinghua University. After 2018, he engaged in industrial consulting research and entered the co-cultivation postdoctoral research at the School of Economics and Management of Tsinghua University, serving as a research assistant. He has an in-depth understanding of the analysis and investment of new global life and health technologies and industries. In 2020, he worked at the Venture lab of DeepTech, engaging in the incubation and investment of synthetic biology. In 2023, he joined PhaBuilder in Beijing as the Vice President.
  • Jinghui Wang
    VP of R&D
    With nearly 11 years of work experience in technology research and development, he served as a senior manager at L'Oréal, possessing extensive management experience in the upstream, midstream, and downstream of R&D. He coordinated and advanced global innovation projects and established a synthetic biology platform. He holds a Ph.D. in Chemical and Bioengineering.
  • Lishuang Cong
    Deputy General Manager of Production
    With 12 years of experience in the research and development, production, industrial scale-up, and the entire GMP production process of fermentation-based APIs (Active Pharmaceutical Ingredients) and pharmaceutical intermediates; proficient in factory management with experience in managing tens of thousands of tons of production. Holds a master's degree in microbiology and is a senior engineer.
Corporate Honors
The Entrepreneurial Journey, Coming with Honors
Zhongguancun High-tech Enterprise
The 8th
High-tech Enterprise
Beijing’s “Specialized, Specialized and New” Small and Medium-sized Enterprises